Searched over 200M research papers
10 papers analyzed
These studies suggest that high blood pressure in acute stroke patients is associated with increased risk of death, disability, and poor outcomes, and that lowering blood pressure with antihypertensive therapy can improve outcomes and reduce the risk of recurrent strokes.
19 papers analyzed
High blood pressure (BP) is a significant risk factor for stroke, which is the second leading cause of death and a major cause of disability worldwide. Elevated BP can lead to both ischemic and hemorrhagic strokes, and managing BP is crucial for both the prevention and treatment of stroke .
Elevated BP is prevalent in a substantial proportion of stroke patients. A study involving 563,704 stroke patients in the United States found that over 60% presented with elevated BP upon arrival at the emergency department. This high prevalence underscores the importance of BP management in acute stroke care.
High BP in acute stroke is associated with poor outcomes, including increased mortality and dependency. A systematic review of 32 studies involving 10,892 patients found that elevated mean arterial BP (MABP) and diastolic BP (DBP) were significantly associated with higher odds of death. Specifically, high systolic BP (SBP) and DBP were linked to combined death or dependency in primary intracerebral hemorrhage (PICH) and ischemic stroke.
Lowering BP has been shown to reduce the risk of recurrent stroke and other vascular events. A systematic review of randomized controlled trials demonstrated that antihypertensive therapy significantly reduced the odds of stroke recurrence, nonfatal stroke, myocardial infarction, and total vascular events in patients with a history of stroke or transient ischemic attack.
Managing BP in acute stroke is complex due to the loss of normal cerebral autoregulation. High BP can lead to cerebral edema, hematoma expansion, or hemorrhagic transformation, while low BP can result in increased cerebral infarction or perihematomal ischemia. Therefore, the decision to modulate BP must be carefully considered.
Evidence from multiple large, high-quality randomized trials suggests that BP lowering is recommended in acute intracerebral hemorrhage and is safe in ischemic stroke. However, the optimal BP targets and treatment strategies remain areas of ongoing research.
Certain features of BP, such as nocturnal hypertension, morning surge, and increased variability, are associated with an increased risk of stroke. However, there is no universally accepted modality for correcting these disturbances, and further research is needed to identify effective interventions.
Patients with very high BP in acute stroke tend to be younger and have a more frequent history of hypertension. Alcohol abuse is also more common in this group, which may contribute to the severity of hypertension and its complications.
High blood pressure is a critical factor in the incidence and outcomes of stroke. Effective management of BP in both the acute and long-term phases of stroke care is essential to reduce mortality, dependency, and recurrence of vascular events. Ongoing research and clinical trials will continue to refine the strategies for optimal BP management in stroke patients, aiming to improve overall outcomes and quality of life.
Most relevant research papers on this topic